A drug that helps limit the overgrowth of normal tissue in your artery as the healing process occurs following coronary stent implantation. Overgrowth of normal tissue is thought to be a major factor responsible for re-narrowing of the artery after stent implantation.

Another name for Rapumane, one of the drugs used to prevent the body from rejecting the islet transplants.

A drug used to help prevent rejection of organ and bone marrow transplants by the body.

Sirolimus (INN) is a relatively new immunosuppressant drug used to prevent rejection in organ transplantation, and is especially useful in kidney transplants. It is also known as rapamycin. Sirolimus is a macrolide antibiotic ("-mycin") first discovered as a product of the bacterium Streptomyces hygroscopicus in a soil sample from an island called Rapa Nui, better known as Easter Island.